19/01/2026

The Echopoint Medical team recently attended the annual JPM Healthcare Conference in San Francisco, taking part in a week of highly productive meetings and discussions across the healthcare ecosystem.

One message came through clearly: Coronary Microvascular Disease (CMD) is increasingly recognised as a significant and underdiagnosed clinical problem. Whether it’s clinicians, bankers or investors –  there is growing awareness of the diagnostic gap that leaves many patients without clear answers or targeted treatment.

At Echopoint Medical, we are addressing this unmet need. The iKOr system is designed to deliver rapid, accurate diagnosis of CMD within existing clinical workflows. And as we progress toward further clinical validation, we believe the timing is right—aligned with an industry that is increasingly focused on improving outcomes for patients with CMD.